These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15997769)

  • 1. [Relationship between blood PCDFs level and symptoms in Yusho patients].
    Kanagawa Y; Imamura T
    Fukuoka Igaku Zasshi; 2005 May; 96(5):169-79. PubMed ID: 15997769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Steps for establishment of the diagnostic standard in Yusho patients].
    Furue M; Uenotsuchi T
    Fukuoka Igaku Zasshi; 2005 May; 96(5):124-34. PubMed ID: 15997763
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ophthalmologic findings in Yusho patients].
    Nakamura T; Miyazaki M; Onishi K; Ishibashi T
    Fukuoka Igaku Zasshi; 2005 May; 96(5):157-63. PubMed ID: 15997767
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concentrations of PCDDs, PCDFs and coplanar PCBs in blood of 83 patients with Yusho].
    Iida T; Hirakawa H; Matsueda T; Nakagawa R
    Fukuoka Igaku Zasshi; 1997 May; 88(5):169-76. PubMed ID: 9194337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood chemical analysis and alpha-fetoprotein and HBs analysis in Yusho patients].
    Tsuji H; Ito Y
    Fukuoka Igaku Zasshi; 2005 May; 96(5):180-2. PubMed ID: 15997770
    [No Abstract]   [Full Text] [Related]  

  • 6. [Levels of PCDDs, PCDFs and coplanar PCBs in sebum and blood of Yusho patients].
    Iida T; Hirakawa H; Matsueda T; Hori T; Nakao T; Nakayama J
    Fukuoka Igaku Zasshi; 1997 May; 88(5):177-85. PubMed ID: 9194338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change of PCDF and PCB concentrations in the blood of Yucheng and Yusho patients for 25 years].
    Masuda Y; Haraguchi K; Kuroki H; Ryan JJ
    Fukuoka Igaku Zasshi; 1995 May; 86(5):178-83. PubMed ID: 7628805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The changes of PCBs and PCDFs as well as symptoms in Yusho patients for 30 years].
    Masuda Y; Haraguchi K; Kuroki H; Ryan JJ
    Fukuoka Igaku Zasshi; 2001 May; 92(5):149-57. PubMed ID: 11452512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the application of residual PCBs, PCQs and PCDFs concentrations to Yusho diagnosis].
    Nakagawa R; Takahashi K
    Fukuoka Igaku Zasshi; 1991 May; 82(5):280-94. PubMed ID: 1916601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotive excretion of causative agents of Yusho by one year intake of FBRA in Japanese people.
    Nagayama J; Takasuga T; Tsuji H; Iwasaki T
    Fukuoka Igaku Zasshi; 2005 May; 96(5):241-8. PubMed ID: 15997780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Time serial changes in the concentrations of the etiological agents of fetal Yusho--PCDDs and PCDFs].
    Nagayama J; Todaka T; Hirakawa H; Hori T; Kajiwara J; Yoshimura T
    Fukuoka Igaku Zasshi; 2011 Apr; 102(4):109-15. PubMed ID: 21706889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trend of PCB/PCDF concentrations in the blood of Yusho patients for 38 years after the incidence].
    Masuda Y; Yoshimura T; Kajiwara J; Ryan JJ
    Fukuoka Igaku Zasshi; 2007 May; 98(5):182-95. PubMed ID: 17642296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs) from human blood in the Yusho and Yu-Cheng rice oil poisonings.
    Ryan JJ; Levesque D; Panopio LG; Sun WF; Masuda Y; Kuroki H
    Arch Environ Contam Toxicol; 1993 May; 24(4):504-12. PubMed ID: 8507107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impaired mitogen-induced lymphocyte transformation in patients with Yusho].
    Tsuji H; Ito Y
    Fukuoka Igaku Zasshi; 2011 Apr; 102(4):81-6. PubMed ID: 21706884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of PCBs, PCDFs and PCDDs in the blood of Yusho patients and their toxic equivalent contribution.
    Masuda Y; Schecter A; Päpke O
    Chemosphere; 1998; 37(9-12):1773-80. PubMed ID: 9828305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of estradiol, progesterone and prolactin in patients with Yusho].
    Tsuji H; Ikeda M
    Fukuoka Igaku Zasshi; 2007 May; 98(5):166-9. PubMed ID: 17642293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxic effects and pharmacodynamics of PCB and PCDF in Yusho patients during the last 35 years].
    Mstsuda Y; Haraguchi K
    Fukuoka Igaku Zasshi; 2005 May; 96(5):113-23. PubMed ID: 15997762
    [No Abstract]   [Full Text] [Related]  

  • 18. [Follow-up survey of dioxins in the blood of Yusho patients (in 1998-1999)].
    Takenaka S; Hirakawa H; Nakamura M; Nakagawa R; Iida T; Todaka T
    Fukuoka Igaku Zasshi; 2001 May; 92(5):139-48. PubMed ID: 11452511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic trial for promotion of fecal excretion of PCDFs and PCBs by the administration of cholestyramine in Yusho patients].
    Iida T; Hirakawa H; Matsueda T; Nakagawa R; Takenaka S; Morita K; Narazaki Y; Fukamachi K; Tokiwa H; Takahashi K
    Fukuoka Igaku Zasshi; 1991 May; 82(5):317-25. PubMed ID: 1916604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human body burden of polychlorinated dibenzofurans associated with toxicity based on the yusho and yucheng incidents.
    Ryan JJ; Gasiewicz TA; Brown JF
    Fundam Appl Toxicol; 1990 Nov; 15(4):722-31. PubMed ID: 2128284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.